Among these three genes, KRAS exhibits the highest mutation frequency in pancreatic ductal adenocarcinoma and is correlated with non–small cell lung carcinoma (NSCLC) and colorectal carcinoma (2–4). This evidence concerns the gene KRAS and non-small cell lung carcinoma.